Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Vet Parasitol ; 316: 109890, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36878106

ABSTRACT

Bovine trichomonosis (BT), a disease of the bovine urogenital tract, is caused by the protozoan Tritrichomonas foetus (Tf). Tf causes endometritis, infertility, and premature death of the embryo, which generates considerable economic losses. The proteins released can mediate fundamental interactions between the pathogen and the host, triggering factors associated with the symptomatology, immune evasion and pathogenesis characteristic of the species. However, little is known about the profile of the proteins released by Tf. In order to contribute to their knowledge, we performed an isolation protocol and a proteomic profiling of the supernatant (SN) content of six Tf isolates. A total of 662 proteins present in the SN of Tf were detected, out of which 121 were shared by the six isolates, while the remaining 541 were found in at least one of the isolates studied. The comparative analyses using the databases of Tf strain genome K revealed 32.9% of uncharacterized proteins. The bioinformatic analyses showed that the main molecular functions predicted were binding (47.9%) and catalytic activity (38.2%). Additionally, we performed immunodetection assays to evidence the antigenic potential of SN proteins. Interestingly, we observed great ability to detect SN proteins from all six isolates using serum from immunized mice and infected bulls. A complementary mass spectrometry assay allowed us to determine that the proteins that showed the strongest signal intensity in the immunoassays were Grp78 (A0A1J4IZS3) and Ap65 (A0A1J4JSR1). This work represents the first proteomic characterization of Tf SN proteins and their antigenic potential, which might be interesting for the future design of new diagnosis and treatment methods for BT.


Subject(s)
Cattle Diseases , Protozoan Infections, Animal , Trichomonas Infections , Tritrichomonas foetus , Female , Animals , Cattle , Male , Mice , Protozoan Infections, Animal/diagnosis , Proteomics , Trichomonas Infections/veterinary , Cattle Diseases/diagnosis
2.
Vet Parasitol ; 267: 84-89, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30878091

ABSTRACT

Bovine Trichomonosis, an endemic sexually transmitted disease in countries with extensive livestock and natural service, represents one of the most common causes of reproductive failure. 5-nitroimidazoles and their derivatives are used for its treatment, mainly metronidazole (Mz). The emergence of resistance mechanisms adopted by the parasites against the drug and failure of the treatments suggest the need to investigate susceptibility and obtain current values. The available information of in vitro susceptibility of these drugs comes from the use of a diversity of methodologies and criteria, especially observation of the mobility of the parasite under the optical microscope to evaluate its viability. These techniques are arduous and time consuming and lead to a subjective assessment dependent on the operator, the methodology used, and the morphology adopted by the protozoan. In this sense, flow cytometry has proven to be a fast and efficient method to evaluate viability in other protozoa. The aim of this study was to evaluate the in vitro susceptibility of six bovine isolates of Tritrichomonas foetus to Mz in aerobic (AC) and anaerobic (ANC) conditions by means of the calculation of the 50% inhibitory concentration (IC50), by flow cytometry, and also to analyze minimum lethal concentration (MLC) by means of recovery tests post-treatment in vitro. IC50 values ranged from 1.06 to 1.25 µM in ANC and from 1.44 to 3.03 µM in AC, these being the only ones reported at 48 h for these protozoa. With respect to MLC at 48 h, the results were from 3.67 to 7.35 µM in ANC, and from 7.35 to 14.7 µM for AC, where two isolates (Tf0 and Tf2) for AC and one (Tf2) for ANC showed higher values than those described in the literature. Flow cytometry has proven to be an effective, rapid and objective methodology and very useful in susceptibility tests. The data obtained through these tests allow us to describe the susceptibility exhibited by these protozoa, this being valuable information when establishing dosages in Mz treatments.


Subject(s)
Flow Cytometry , Metronidazole/pharmacology , Parasitic Sensitivity Tests , Tritrichomonas foetus/drug effects , Animals , Cattle/parasitology , Inhibitory Concentration 50 , Nitroimidazoles/pharmacology
3.
Acta Parasitol ; 64(2): 232-235, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30783992

ABSTRACT

BACKGROUND: Tritrichomonas foetus is the etiologic agent of the sexually transmitted disease Bovine Trichomonosis (BT). In Argentina, BT is endemic and represents a relevant health problem that causes reproductive inefficiency in cattle and large economic losses. Metronidazole is the drug of choice in the treatment of BT. Treatment has been associated with a temporary resolution of the clinical signs but is not able to control the disease. In recent years, the apparition of in vivo and in vitro aerobic and anaerobic resistance leading to ineffective treatments has been reported. AIMS: Thus, the aim of the present study was to explore the susceptibility of six different isolates of T. foetus under aerobic (AC) and anaerobic (ANC) conditions. RESULTS AND DISCUSSION: Six isolates of T. foetus were obtained from samples of preputial smegma of bovine origin. Values of minimum lethal concentration and minimum inhibitory concentration were higher than those observed in other works and represent current data in Argentina and provide information to establish new treatment protocols.


Subject(s)
Antiprotozoal Agents/pharmacology , Metronidazole/pharmacology , Tritrichomonas foetus/drug effects , Aerobiosis , Anaerobiosis , Animals , Argentina , Cattle , Cattle Diseases/parasitology , Protozoan Infections, Animal , Trichomonas Infections/veterinary , Tritrichomonas foetus/isolation & purification
4.
Plant Physiol ; 165(4): 1698-1708, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24948827

ABSTRACT

The current consensus is that plant responses to canopy shade involve the perception of low red to far-red ratios (R:FRs) by phytochrome B (phyB), which leads to the direct activation of auxin synthesis genes by PHYTOCHROME INTERACTING FACTORs (PIFs). In addition to its effect on R:FRs, shade also reduces irradiance, but whether shade-induced drops in irradiance affect phyB activity has not been demonstrated. To address this issue, we investigated whether irradiance and R:FRs have similar effects on the nuclear distribution of phyB in petiole cells of light-grown plants. Under high-irradiance white light, phyB formed large nuclear bodies. Lowering irradiance without changing R:FRs or lowering R:FRs by adding far-red light led to the appearance of small nuclear bodies containing phyB. Large nuclear bodies remained but with some concomitant reduction in diameter. The appearance of small nuclear bodies was rapid, stable, and reversible upon the return to high irradiance and high R:FRs. High levels of red light but not of blue light were enough to restrain the formation of small phyB nuclear bodies. Irradiance was effective within the range found in natural canopies and even under relatively low R:FRs. The promotion of leaf hyponasty by lowering irradiance was impaired in phyB and pif mutants, as previously reported for the response to R:FRs. The expression of auxin-related genes showed a similar hierarchy of response to low R:FRs and low irradiance. We propose that phyB is able to perceive not only the low R:FRs, but also the low irradiance of shade.

5.
Invest Clin ; 50(2): 153-61, 2009 Jun.
Article in Spanish | MEDLINE | ID: mdl-19662811

ABSTRACT

Codon 72 polymorphism of the tumor suppressor gene TP53 has been associated with a higher risk in the development of several types of cancer. The polymorphism results in a variant protein with either an arginine (CGC) or a proline residue (CCC). The aim of this study was to analyze the association of the TP53 codon 72 polymorphism with the risk of developing gastric cancer in a high-risk population from the central-western region of Venezuela. DNA was extracted from paraffin-embedded gastric adenocarcinoma biopsies (n=65) and endoscopic biopsies from chronic gastritis patients (n=87). TP53 codon 72 polymorphism was determined by PCR-RFLP from all samples. Patients with gastric cancer had a significantly higher frequency (P = 0.037) of the Arg allele than those with chronic gastritis. A logistic regression analysis suggested that Arg carrier individuals had a 4.6-fold higher risk (95% CI 1.0-21.3) of developing gastric cancer. An increment of the Arg/Arg genotype was observed in poor-differentiated gastric adenocarcinoma (OR: 3.1; 95% CI 1.0-9.2), and of the Arg/Pro genotype in well/moderate-differentiated adenocarcinoma samples (OR: 3.5; 95% CI 1.1-11.0), when comparing within the gastric cancer samples; and the last group also when contrasting it with chronic gastritis patients (OR: 2.4; 95% CI 1.1-5.2). The results of this study suggest that the carriage of the Arg allele could be associated with the development of gastric cancer in this Venezuelan population.


Subject(s)
Adenocarcinoma/genetics , Codon/genetics , Genes, p53 , Polymorphism, Single Nucleotide , Stomach Neoplasms/genetics , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Alleles , Case-Control Studies , Cell Differentiation , DNA, Neoplasm/genetics , Female , Gastritis/epidemiology , Gastritis/genetics , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Male , Middle Aged , Risk , Stomach Neoplasms/epidemiology , Stomach Neoplasms/pathology , Venezuela/epidemiology , Young Adult
6.
Invest. clín ; 50(2): 153-161, jun. 2009. ilus, tab
Article in Spanish | LILACS | ID: lil-564812

ABSTRACT

El polimorfismo del codón 72 del gen TP53 ha sido asociado con un riesgo elevado para el desarrollo de cáncer. Este polimorfismo origina dos variantes de la proteína, una con un residuo de Arginina (CGC), y otra con Prolina (CCC). El objetivo del estudio fue analizar la asociación de este polimorfismo con el riesgo de desarrollar cáncer gástrico en individuos procedentes de la región centroccidental de Venezuela, considerada de alto riesgo para esta neoplasia maligna. El ADN fue extraído de biopsias de adenocarcinoma gástrico incluídas en parafina (n = 65) y biopsias endoscópicas de pacientes con gastritis crónica (n = 87). El polimorfismo del codón 72 de TP53 fue determinado por PCR-RFLP. Se observó un incremento significativo de la frecuencia del alelo Arg en los pacientes con cáncer gástrico (P = 0,037), originando un riesgo 4,6 veces mayor (95% IC 1,0-21,3) de desarrollar esta enfermedad. Se evidenció un incremento del genotipo Arg/Arg en adenocarcinoma gástrico poco diferenciado (OR: 3,1; 95% IC 1,0-9,2), y del genotipo Arg/Pro en adenocarcinoma de moderado/buen grado de diferenciación (OR: 3,5; 95% IC 1,1-11,0) al comparar con el grupo de cáncer gástrico, y este último también al contrastar con los individuos con gastritis crónica (OR: 2,4; 95% IC 1,1-5,2). Los resultados de este estudio sugieren que la condición de portador del alelo Arg podría estar asociado con el desarrollo de cáncer gástrico en esta región de Venezuela.


Codon 72 polymorphism of the tumor suppressor gene TP53 has been associated with a higher risk in the development of several types of cancer. The polymorphism results in a variant protein with either an arginine (CGC) or a proline residue (CCC). The aim of this study was to analyze the association of the TP53 codon 72 polymorphism with the risk of developing gastric cancer in a high-risk population from the central-western region of Venezuela. DNA was extracted from paraffin-embedded gastric adenocarcinoma biopsies (n = 65) and endoscopic biopsies from chronic gastritis patients (n = 87). TP53 codon 72 polymorphism was determined by PCR-RFLP from all samples. Patients with gastric cancer had a significantly higher frequency (P = 0.037) of the Arg allele than those with chronic gastritis. A logistic regression analysis suggested that Arg carrier individuals had a 4.6-fold higher risk (95% CI 1.0-21.3) of developing gastric cancer. An increment of the Arg/Arg genotype was observed in poor-differentiated gastric adenocarcinoma (OR: 3.1; 95% CI 1.0-9.2), and of the Arg/Pro genotype in well/ moderate-differentiated adenocarcinoma samples (OR: 3.5; 95% CI 1.1-11.0), when comparing within the gastric cancer samples; and the last group also when contrasting it with chronic gastritis patients (OR: 2.4; 95% CI 1.1-5.2). The results of this study suggest that the carriage of the Arg allele could be associated with the development of gastric cancer in this Venezuelan population.


Subject(s)
Humans , Male , Female , Adenocarcinoma/pathology , Biopsy/methods , Codon/adverse effects , Polymorphism, Genetic , Stomach Neoplasms , Medical Oncology
7.
Rev Med Chil ; 137(1): 63-70, 2009 Jan.
Article in Spanish | MEDLINE | ID: mdl-19399323

ABSTRACT

BACKGROUND: Genetic predisposition may play a role in the prevalence of gastric cancer (GC). AIM: To investigate the relationship between selected interleukin-1 (IL-1) loci polymorphisms and gastric cancer risk in the Central-Western region of Venezuela, where gastric cancer represents the first cause of cancer-related deaths. MATERIAL AND METHODS: In a case-control study we compared the frequencies of IL-1B-511 and IL-1B+3954 biallelic polymorphism, and the pentallelic VNTR of IL-IRN in 84 gastric adenocarcinoma paraffin-embedded biopsies and 84 endoscopic biopsies from cancer-free controls. RESULTS: No significant increase in genotypic frequencies in gastric cancer was observed for any of the IL-1B-511 allelic combinations. However, in a logistic regression analysis, a significant association emerged for the IL-1B+3954C carrier genotype (odds ratio (OR): 6.2; 95% confidence intervals (CI) 1.3-28.8). On the other hand, a significantly higher risk was evidenced for the IL-IRN*2/*2 genotype (OR: 7.0; 95% CI2.3-21.5). Only patients with a well/moderately-differentiated adenocarcinoma that were homozygotes for the E-IRN*2/*2 genotype, had a higher risk than the complete gastric cancer group (OR: 8.1, 95% CI 2.5-26.8). Some genotype combinations among IL-1B-511, IL-1B+3954 and IL-IRN showed an increased risk for developing gastric cancer and well/moderate differentiated adenocarcinoma, that was dependent of the presence of IL-IRN*2/*2 genotype. CONCLUSIONS: IL-IRN*2/*2 genotype is associated with increased risk of gastric cancer in the Venezuelan population.


Subject(s)
Adenocarcinoma/genetics , Genetic Predisposition to Disease , Interleukin-1/genetics , Polymorphism, Genetic , Stomach Neoplasms/genetics , Adenocarcinoma/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Gene Frequency , Humans , Male , Middle Aged , Odds Ratio , Risk Factors , Stomach Neoplasms/pathology , Venezuela , Young Adult
8.
Rev. méd. Chile ; 137(1): 63-70, ene. 2009. tab
Article in Spanish | LILACS | ID: lil-511845

ABSTRACT

Background: Genetic predisposition may play a role in the prevalence of gastric cancer (GC). Aim: To investigate the relationship between selected interleukin-1 (IL-1) loci polymorphisms and gastric cancer risk in the Central-Western region of Venezuela, where gastric cancer represents the first cause of cancer-related deaths. Material and methods: In a case-control study, we compared the frequencies of IL-1B-511 and IL-1B+3954 biallelic polymorphism, and the pentallelic VNTR of IL-IRN in 84 gastric adenocarcinoma paraffin-embedded biopsies and 84 endoscopic biopsies from cancer-free controls. Results: No significant increase in genotypic frequencies in gastric cancer was observed for any of the IL-1B-511 allelic combinations. However, in alogistic regression analysis, a significant association emerged for the IL- 1B+3954C carrier genotype (odds ratio (OR): 6.2; 95% confidence intervals (CI) 1.3-28.8). On the other hand, a significantly higher risk was evidenced for the IL-IRN*2/*2 genotype (OR: 7.0; 95% CI 2.3-21.5). Only patients with awell/moderately-differentiated adenocarcinoma that were homozygotes for the IL-IRN*2/*2 genotype, had a higher risk than the complete gastric cancer group (OR: 8.1, 95% CI 2.5-26.8). Some genotype combinations among IL-1B-511, IL-1B+3954 and IL-IRN showed an increased risk for developing gastric cancer and well/moderate differentiated adenocarcinoma, that was dependent of the presence of IL-IRN*2/*2 genotype. Conclusions: IL-IRN*2/*2 genotype is associated with increased risk of gastriccancer in the Venezuelan population.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Adenocarcinoma/genetics , Genetic Predisposition to Disease , Interleukin-1/genetics , Polymorphism, Genetic , Stomach Neoplasms/genetics , Adenocarcinoma/pathology , Case-Control Studies , Gene Frequency , Odds Ratio , Risk Factors , Stomach Neoplasms/pathology , Venezuela , Young Adult
9.
Invest. clín ; 48(4): 485-493, dic. 2007. ilus, graf
Article in Spanish | LILACS | ID: lil-486585

ABSTRACT

Los telómeros son complejos nucleoproteicos que protegen los extremos de cromosomas eucariotas de fenómenos de degradación y recombinación. En humanos, los telómeros miden 10-12 kpb en células somáticas normales, pero pueden reducirse hasta apenas 1-2 kpb en células tumorales de rápido crecimiento, debido a la replicación incompleta de estas estructuras en cada división mitótica. Los telómeros se acortan con la edad, lo cual puede estar asociado a inestabilidad genómica y a un incremento del riesgo de sufrir cáncer. El análisis de fragmentos de restricción teloméricos por Southern blot es en la actualidad el método estándar para la medición de la longitud de los telómeros. Sin embargo, una determinación precisa no es posible cuando el ADN está fragmentado o es escaso, como es el caso de las biopsias incluidas en parafina. En este trabajo se adecuó un ensayo de slot blot para cuantificar el contenido relativo, en lugar de la longitud, del ADN telomérico a partir de muestras de archivo de adenocarcinoma de colon. El contenido de ADN telomérico pudo ser medido de manera reproducible con apenas 75 ng de ADN genómico altamente degradado empleando detección de la hibridización por quimioluminiscencia.


Subject(s)
Humans , Adenocarcinoma , Biopsy , Chromosomes , Colonic Neoplasms/pathology , Medical Oncology , Venezuela
10.
Invest Clin ; 48(4): 485-93, 2007 Dec.
Article in Spanish | MEDLINE | ID: mdl-18271393

ABSTRACT

Telomeres are nucleoprotein complexes that protect the ends of eucaryotic chromosomes from degradation and recombination. In humans, telomeres measure 10-12 kbp in normal somatic cells, but they scarcely reach 1-2 kbp in tumor cells of rapid growth, due to the incomplete replication of these structures in each mitotic division. Telomeres shorten with age, which can be associated to genomic instability and to an increment of the risk of suffering from cancer. The standard method to measure the telomere length is the analysis of telomeric restriction fragments by Southern blot. However, a precise determination is not possible when the DNA is broken into small fragments or if it is scarce. In this work, a slot blot assay was adapted to quantify the relative content, instead of the length, of telomeric DNA from paraffin-embedded archival specimens of colon adenocarcinoma. The telomeric DNA content could be reproducibly measured with hardly 75 ng of highly degraded genomic DNA by chemiluminescent detection for hybridization.


Subject(s)
Adenocarcinoma/chemistry , Colonic Neoplasms/chemistry , DNA, Neoplasm/analysis , Luminescent Measurements/methods , Nucleic Acid Hybridization/methods , Telomere/chemistry , Adenocarcinoma/genetics , Aged , Aged, 80 and over , Bacterial Proteins , Biological Specimen Banks , Biopsy , Biotinylation , Colonic Neoplasms/genetics , DNA Fragmentation , Electrophoresis, Agar Gel , Female , Horseradish Peroxidase , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity , Tissue Fixation/methods
11.
Pharmacol Res ; 54(5): 345-55, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16965921

ABSTRACT

In heart tissue five isoforms of the muscarinic acetylcholine receptor (mAChR) have been identified, designated m1-m5, of which only M1, M2 and M3 have functional evidences for their role in cardiac physiology. The present study was designed to explore the diversity of mAChR subtypes in human hearts and determine whether these subtypes are able to interact themselves. Expression of mRNAs encoding all five subtypes was readily detected by RT-PCR reaction in both atrial (A) and ventricle (V) samples. Immunoblotting, MABA and ELISA with subtype-specific antibodies confirmed the presence of M1, M2, M3, M4 and M5 proteins in membrane preparations from both A and V. Kinetic characterization using [(3)H]-QNB shown: (1) atrium had greater B(max) than did the ventricle, (2) [(3)H]-QNB behave as an allosteric modulator, inducing cooperativity at high and disclosing heterogeneity at low concentrations, (3) heterogenity was observed in pirenzepine, biperiden and tropicamide competition curves, being the high affinity sites compatible with M1 and M4 muscarinic receptor subtypes and (4) methoctramine competition curves in presence of selective muscarinic receptor subtypes antagonist displayed heterogeneity profile still maintaining cooperativity (n(H)>1), indicating muscarinic receptors subtypes are able to form homo- and hetero-oligomers. In conclusion, our results provide molecular and kinetic evidence for the presence of multiple subtypes of mAChR in human hearts, which are able to undergo discrete transitions from a non-cooperative kinetics of non-interacting monomers to a cooperative kinetics of interacting oligomers.


Subject(s)
Heart Atria/metabolism , Heart Ventricles/metabolism , Myocardium/metabolism , Receptors, Muscarinic/metabolism , Adult , Binding, Competitive , Gene Expression Regulation/drug effects , Heart Atria/drug effects , Heart Ventricles/drug effects , Humans , In Vitro Techniques , Male , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , RNA, Messenger/metabolism , Radioligand Assay , Receptors, Muscarinic/genetics , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...